Skip to main content
. 2022 Aug 8;34(1):33. doi: 10.1186/s43046-022-00137-0

Fig. 2.

Fig. 2

Schematic representation of various action of NSAIDs through different targets and its consequences in various conditions and cancer types. NSAIDS have been known to inhibit NF-KB, COX-1, COX-2, 5 LOX, PAF, and PP2A respectively, and supress EGFR in different cancer types